The Indian government has restricted access to 13 key drugs in anticipation of COVID-19 related demand, potentially causing a major disruption to drug supply chains globally. TiVO’s patent victory comes as set-top box imports are falling. Also: Maersk’s integrated strategy bears fruit with India service launch; Target’s prepared for COVID-19 as new year imports slip; New York joins roster of ports expecting COVID-19 disruptions; EC green deal legislation carries two risks for global supply chains; More uncertainty, less power as section 232 restriction bill reanimates; and the economic t...